Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
USFDA okays Alembic Pharma Dabigatran Etexilate Capsules Ruchika Sharma7 April 2022 3:41 PM ISTDabigatran Etexilate capsules, are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult...
Boehringer operating income edges up on Jardiance, animal health Ruchika Sharma6 April 2022 9:00 AM ISTFrankfurt: Germany's unlisted Boehringer Ingelheim said operating income rose 1.8% in 2021, driven by more prescriptions of diabetes drug Jardiance...
Boehringer Ingelheim gets USFDA Breakthrough Therapy Designation for BI 1015550 MD Bureau28 Feb 2022 11:00 AM ISTGermany: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation to its...
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
Boehringer Ingelheim bags Guinness World Records title for stroke awareness campaign Ruchika Sharma26 Nov 2021 3:35 PM ISTNew Delhi: Boehringer Ingelheim India, has recently announced that the company has achieved the Guinness World Records title for "Most...
USFDA approves Alembic Pharma Dabigatran Etexilate Capsules Ruchika Sharma23 Nov 2021 2:31 PM ISTMumbai: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food &...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 11:24 AM ISTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 29/October/2021 Roshni Dhar30 Oct 2021 11:09 AM ISTHere are Top Health Stories of the dayMadras HC slams Medical Council for removing gastroenterologist's name, gives 14 pointer guidelinesSlamming the...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Health Bulletin 25/October/2021 Roshni Dhar25 Oct 2021 4:23 PM ISTHere are Top Health Stories of the dayDoctors cannot function under threat of being harassed, beaten up: High CourtThe Punjab and Haryana High Court...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
